ImmunologybioRxiv
Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease.
R. Kalla, A. T. Adams, D. Bergemalm…·J. Satsangi
This study identifies a serum protein panel that distinguishes inflammatory bowel disease from non-IBD controls and predicts treatment escalation.
DOI 10.1093/ecco-jcc/jjaa230